Agreement Preamble Sample Clauses
POPULAR SAMPLE Copied 2 times
Agreement Preamble. As Adjusted Voting Basis 12.02 Board of Managers 1.01 Board Observers 3.02(f) Budget 2.08(a)(iv) Capital Account 12.02 Capital Contribution 12.02 CEO 4.01 CEO Manager 3.02(b)(iii Certificate 1.01 Change of Control 12.02 Code 12.02 Common Units 2.10(a) Company Preamble Company Notice 12.02 Company Refusal Period 10.03(c) Company Undersubscription Notice 10.03(e) Company’s Expiration Notice 10.03(c) Control 12.02 Convertible Securities 8.06(e)(i) Corporate Conversion 10.11(a) Covered Persons 3.10(b) Deep Track 12.02 Deep Track Board Observer 3.02(f) DGCL 5.01 Disqualification Event 2.02 Disqualified Designee 2.02 Economic Capital Account 12.02 Exchange Act 12.02 Exempted Securities 12.02 Existing Agreement Preamble Expenses 5.06(b) Fair Market Value 12.02 Fairmount Managers 3.02(b)(ii) Fairmount Members 12.02 FCPA 5.13 Fidelity Member 12.02 Fiscal Year 1.04 Fully Exercising Investors 10.03(e) Holdings 10.11(a) Holdings Reduced Equity 10.11(a) Imputed Underpayment Amount 13.01(b) Incentive Units 2.10(a) Indemnified Person 5.06(a) Initial Consideration 11.03(d) Initial Equity Allocation 10.11(a) Investor Business Opportunity 3.10(b) Investor Counsel 5.11 Investor Notice Period 10.03(e) IPO 12.02 Major Investor 12.02 Manager 12.02 Mandatory Conversion Time 8.12(a) Member Preamble Member Representative 10.07(b)(vii) New Securities 12.02 Offer Notice 10.12(a) Options 8.06(e)(i) Officer 4.01 OrbiMed 12.02 Other Indemnitors 5.02 Paragon Member 12.02 Participating Preferred Member 10.04(a) Partnership Representative 3.04(h) Pass -Through Entities 9.08 Percentage Interest 12.02 Permitted Transfer 10.01(a) Permitted Transferee 10.01(a) Person 12.02 Preferred Member 12.02 President 4.01 Proceeding 5.06(c) Proceeds 8.01(b) Proceeds Available for Distribution 12.02 Prohibited Transfer 10.05(c) Prohibited Transferees 10.06(c) Proposed Sale 10.07(c) Proposed Transfer 12.02 Proposed Transferee 12.02 Purchase Agreement Preamble Purchase Notice 10.03(d) Qualified IPO 8.12(a) RA Capital 12.02 Released Securities 10.13(b) Requisite Preferred Holders 12.02 Requisite Series A Preferred Holders 12.02 Requisite Series B Preferred Holders 12.02 Right of Co-Sale 12.02 Right of First Refusal 12.02 ROFR Subject 10.03(a) RTW Funds 12.02 RTW Board Observer 3.02(f) Rule 506(d) Related Party 12.02 Sale Event 11.03(a) Sale of the Company 10.07(a) Secondary Offer Notice 10.12(b) Secretary 4.01 Securities Act 2.02 Selling Holders 10.07(b) Series A Adjustment Price 12.02 Series A Adjustment Ra...
Agreement Preamble. Aggregate Consideration Section 1.6(c) Aggregate Consideration Per Share Section 1.6(c) beneficial owner Section 8.4(b) Book-Entry Shares Section 1.10(b) business day Section 8.4(c) Canadian Company Sale Section 6.2(d) Canadian Plan Section 2.12(a) Cash Designated Shares Section 1.9(e)(ii)(B) Cash Election Shares Section 1.9(b) Certificate of Merger Section 1.2 Certificates Section 1.10(b) Change in the Company Recommendation Section 5.3(b) Closing Section 1.2 Closing Date Section 1.2 Code Recitals Company Preamble Company 401(k) Plan Section 2.12(a) Company Benefit Plans Section 2.12(f) Company Board of Directors Section 2.4(d) Company Common Stock Recitals Company Employees Section 2.18 Company Employee Benefit Plans Section 2.12(c) Company ERISA affiliate Section 2.12(a) Company Financial Advisors Section 2.4(d) Company Material Adverse Effect Section 2.1 Company Material Contracts Section 2.21(a) Company Material Subsidiaries Section 2.1 Company Pension Plan Section 2.12(a) Company Permits Section 2.6(c) Company Preferred Stock Section 2.3 Company Recommendation Section 5.1(e) Company Reserve Reports Section 2.14(c) Company Rights Plan Section 2.3 Company Schedule Article III Company SEC Reports Section 2.7(a) Company Stockholder Approval Section 5.1(e) Company Termination Fee Section 7.3(a) Confidentiality Agreement Section 5.2(b) control Section 8.4(d) controlled by Section 8.4(d) Debt Financing Section 5.10(a) Deemed Shares Outstanding Section 1.6(c) Delaware Law Recitals Dissenting Share Section 1.8(a) Effective Time Section 1.2 Election Deadline Section 1.9(b) Election Form Section 1.9(a) Election Form Record Date Section 1.9(a) Employment Agreement Section 4.1(f) Environmental Laws Section 2.17(a) ERISA Section 2.12(a) Exchange Act Section 2.5(b) Exchange Agent Section 1.10(a) Exchange Fund Section 1.10(a) Exchange Ratio Section 1.6(c) Expenses Section 7.3(d) Final Parent Stock Price Section 1.6(c) Funds Section 5.10(a) GAAP Section 2.1 good and defensible title Section 2.14(e) governmental authority Section 8.4(e) Hazardous Substance Section 2.17(a) HSR Act Section 2.5(b) Hydrocarbons Section 2.14(b) Indemnified Parties Section 5.4(b) Intellectual Property Section 2.20 IRS Section 2.12(a) Letter Section 3.23 Mailing Date Section 1.9(a) Merger Recitals Merger Consideration Section 1.6(a) Merger Sub Preamble NCOC 401(k) Section 2.12(a) NCOC MP Plan Section 2.12(a) Non-Election Shares Section 1.9(b) Notice of Intended Change in the Company Recommen...
Agreement Preamble. All Risks Preamble All Risks Interests Recitals All Risks Shares Recitals Allocation Schedule Section 8.01(f)(iii) Alternative Financing Section 5.13(a) AmRisc Section 9.05(c) Ancillary Agreements Section 9.05(c) Balance Sheet Section 3.05(a) Balance Sheet Date Section 3.05(a) Benefit Plan Section 3.18(a) Binding Authority Section 9.05(c) Bonus Pool Section 9.05(c) Bonus Pool Taxes Amount Section 9.05(c) Broker Section 9.05(c) Business Broker Section 9.05(c) Business Carrier Section 9.05(c) Business Day Section 9.05(c) Contract Section 2.03 Conversion Section 8.01(f)(i) Conversion Documentation Section 8.01(f)(i) Converted Company Section 8.01(f)(i) Convertible Securities Section 9.05(c) Core Ancillary Agreement Section 9.05(c) Cortezi Rollover Amount Section 9.05(c) Carrier Section 9.05(c) Cash Section 9.05(c) Casualty Proceeds Section 9.05(c) Certain Counterparties Section 5.07(b) Change of Control Payment Section 9.05(c) Closing Section 1.02 Closing Cash Section 9.05(c) Closing Date Section 1.02 Closing Date Amount Section 1.03(b)(i) Closing Indebtedness Section 9.05(c) Code Section 9.05(c) Commitment Letters Section 4.06 Companies Preamble Companies’ Fundamental Representations Certificate Section 6.02(a) Companies’ Non-Fundamental Representations Certificate Section 6.02(a) Company Preamble Company Contracts Section 3.12(b) Company Data Section 3.10(b) Company Group Section 9.05(c) Company Intellectual Property Section 3.09(a) Company IT Systems Section 3.10(a) Company Material Adverse Effect Section 9.05(c) Company Returns Section 3.15(a) Company Subsidiary Section 9.05(c) Competitive Activities Section 5.11(a)(i) Confidentiality Agreement Section 5.04(a) Consent Section 2.03 Final Bonus Pool Taxes Amount Section 1.04(c) Final Closing Indebtedness Section 1.04(c) Final Seller Transaction Expenses Section 1.04(c) Final Working Capital Section 1.04(c) Finance Contracts Section 9.05(c) Financing Section 4.06 Financing Sources Section 9.05(c) Fraud Section 9.05(c) FTC Section 5.05(c) Fundamental Representations Section 9.05(c) Covered Claim Section 9.11 Covered Employee Section 5.07(b) Creditors Section 1.04(a) Current Assets Section 1.04(g) Current Liabilities Section 1.04(g) Cyber Premium Amount Section 1.03(a)(xi) Debt Commitment Letter Section 4.06 DOJ Section 5.05(c) DRE Election Section 8.01(f)(i) Earliest Closing Date Section 1.02 Employment Agreements Section 6.02(f) Environmental Laws Section 9.05(c) Equity Commitment Letter Section 4.06 Equity ...
Agreement Preamble. Aggregate Purchase Price 1.2 Amended Articles 1.1 Acquired Shares 1.2 Balance Sheet Date 2.7(a) Bankruptcy and Equity Exceptions 2.2 Closing 1.5 Closing Date 1.5 Code 2.10 Common Stock 2.4(a) Company Preamble Company Assets 2.11 Conversion Shares 2.5 Disclosure Schedule Section 2 Entity Investor 3.1 Equity Incentive Plan 2.4(d) Existing Stockholders Preamble FCPA 2.24 Financial Institution 3.11(a) Financial Statements 2.7(a) Founders Preamble GAAP 2.7(b) Governmental Entity 2.3(a) Investment Transaction Recitals Investor[s] Preamble Non-Competition Agreement 2.18(c) OFAC 3.11(a) Offering Memorandum 2.23(a) Options 2.4(e) Outstanding Plan Options 2.4(d) Per Share Price 1.2 PIIA Agreement 2.18(c) Preferred Stock 2.4(a) Purchaser Party 3.11(a) Registration Rights Agreement Recitals Securities 3.4 Securities Act 2.3(b) Series A Preferred Stock 2.4(a) Series B Preferred Stock Recitals Small Business Act 2.27 Specially Designated Nationals and Blocked Persons 3.11(a) State Secretary 5.7 Stockholders Agreement Recitals U.S. Person 3.11(a)
Agreement Preamble. Business 1.1 Business Day 1.1 Certificate or Instrument 1.1 Closing 2.3(a) Closing Date 2.3(a) Company Preamble Company Certificate of Incorporation 1.1 Company Common Stock 1.1 Contract 1.1 e-mail 6.5 Encumbrance 1.1 Event 1.1
Agreement Preamble. Bankruptcy and Equity Exceptions 2.2(a) Board of Directors (or Board) 2.2(b) Company Preamble Conversion Shares 2.2(a) Convertible Note(s) 1.1 Governmental Entity 2.3(a) Investor Preamble Loan 1.1 Loan Date 2.9 Loan Documents 2.2(a) Options 2.4(c) Preferred Stock 2.4(a) Securities 2.5(b) Securities Act 2.5(b) September 2015 Convertible Note 1.1
Agreement Preamble. This Agreement is negotiated pursuant to the Ohio Public Employee Collective Bargaining Act (Chapter 4117 of the Ohio Revised Code). The parties agree that there is no waiver of any of the rights granted under the Act. Where a provision of this Agreement conflicts with state law, this Agreement shall prevail. The Cleveland Metropolitan School District and the Cleveland Teachers Union jointly affirm their commitment to providing a quality education for all of Cleveland’s children. The term children includes students in both elementary and secondary grades. The Cleveland Metropolitan School District and the Cleveland Teachers Union mutually recognize that a safe and secure learning and working environment is essential to the achievement of the educational goals and objectives of the District. Accordingly, the District reaffirms its commitment to provide for the safety of students, employees, parents, and all other school community stakeholders. All stakeholders in the Cleveland Metropolitan School District shall treat one another with professionalism and respect, recognizing that the ultimate success of the District in educating Cleveland’s children requires the efforts of each and every individual.
Agreement Preamble. Applicable Fraction Section 1.36(i)-(v) Breach Issue Recitals Commercialization Agreement Section 3.2(a) Confidential Information Section 6.2 Courts Section 11.2 Deciding Bankers Section 3.2(b) Effective Date Preamble Effective Time Section 9.5(b) First Sales Date Estimate Section 3.3 GK Statement Recitals Glucokinase Activator Section 1.11 Indemnified Party Section 8.3(a) Indemnifying Party Section 8.3(a) Infringement Claim Section 5.5 Invalidity Claim Section 5.4 Novo Preamble Novo Parties Section 8.2 Paragraph IV Claim Section 5.3(a) Partner Deadline Section 3.2(a) Product Liability Section 8.1(c)(ii)(A) Prosecution Section 5.2(a) Released Group Section 10.1 Releasing Group Section 10.1 Releasor Section 10.1 Reverting Rights Section 2.1(a) Royalty Term Section 4.2(c) Stand-by License Agreement Section 9.5(b) Term Section 9.1 Third-Party Claims Section 8.1(c) TransTech Preamble TransTech Parties Section 8.1 Umbrella Agreement Recitals
Agreement Preamble. Alliance Manager 3.1 Anti-Corruption Laws 12.7(a)(i) Audited Party 9.10(b)(i) Auditing Party 9.10(b)(i) Breach Notification 15.2(b)(i) BTC Data Package 1.65 Claims 13.1 Clinical Supply Agreement 7.3(b) CMO 7.2 Commercial Supply Agreement 7.3(c) Commercialization Milestone Event 9.4 Commercialization Milestone Payment 9.4 Commitments Log 4.1 Confidentiality Agreement 17.11 Continuing Technology Transfer 4.1 Disclosing Party 1.21 Dispute 17.5(a) DMF 6.3 DOJ 16.2(a) Excluded Claim 1.1(e) Execution Date Preamble Executive Officers 17.5(a) Executive Sponsors 3.2(f) Existing Regulatory Materials 12.2(s) Ex-Territory Infringement 14.4(a) First BLA 6.2(b) FTC 16.2(b) Global Brand Elements 8.3(c) HSR Filing 16.1(a) ICH Guidelines 1.37 Indemnified Party 13.3 Indemnifying Party 13.3 Initial Technology Transfer 4.1 Jazz Preamble Jazz Collaboration IP 14.1(a) Jazz Collaboration Patent Rights 14.3(d) Jazz Competing Product 1.1(a) Jazz Indemnitee(s) 13.2 Jazz Publication 11.1(b) Joint Collaboration IP 14.1(a) Joint Patent Rights 14.1(d) JSC 3.2(a) License 2.1(b) Losses 13.1 Manufacturing Technology Transfer 7.2 Manufacturing Technology Transfer Plan 7.2 Manufacturing Transition Date 7.3(a) Manufacturing Working Group 3.2(g)(ii) Negotiation Period 2.8 Notice of Dispute 17.5(a) Offered Rights 2.8 Parties Preamble Party Preamble Patent Liaison 14.2 [*** ***] Post-Approval Commitments 6.7(b) PPQ 7.4(a) Product Infringement 14.4(a) Product Marks 14.9(a) Public Official 12.7(d) Publication 11.1(c) Quality Technical Agreement 7.3(d) Receiving Party 1.21 Regulatory Milestone Event 9.3 Regulatory Milestone Payment 9.3 Regulatory Working Group 3.2(g)(iii) Request Period 2.8 Review Period 11.1(b) Royalty Floor 9.6(c)(iii) Royalty Term 9.6(b) Safety Working Group 3.2(g)(iv) SDEA Agreement 6.4 SEC 11.3(c) Second Payment 9.1(b) Second Payment Due Date 9.1(b) Second Request 16.1(b) Securities Regulators 11.3(c) Technology Transfer 4.1 Term 15.1 Territory Development Plan 5.4 Upfront Payment 9.1(a) Western Europe 1.60 Working Group 3.2(g)(i) [*** ***] Zanidatamab 1.50 Zymeworks Preamble Zymeworks Collaboration IP 14.1(a) Zymeworks Competing Product 1.1(b) Zymeworks Development Plan 5.2(a) Zymeworks Domain Names 14.9(b)(v) Zymeworks Indemnitee(s) 13.1 Zymeworks Manufacturing IP 7.2 Zymeworks Platform Patents 1.79 Zymeworks Publication 11.1(c)
Agreement Preamble. Applicable Limitation Date 8.1(a) Arbitrable Dispute 10.13 Arbitrators 10.13(b) Authorized Action 9.7(d) Basket 8.2(d)(ii) Business Preamble Buyer Preamble Buyer Commission Reports 5.6(a) Buyer Parties 8.2(a) Cap 8.2(d)(ii) Closing 2.9 Closing Date 2.9 Closing Statement 2.12(a) Closing Working Capital 2.12(a) Commission 5.5 Common Stock Preamble Company Preamble Company Contracts 3.11(b) Company Copyrights 3.12(a) Company Marks 3.12(a) Company Patents 3.12(a) Company Shares Preamble Company Trade Secrets 3.12(b)(xiii) Confidential Information 9.5(c) Contingent Payments 2.10 Contingent Workers 3.17(a) Copyrights 1.1 (definition of Intellectual Property Assets) Costs and Fees 10.13(c)(i) Dispute Notice 2.12(a) Estimated Closing Working Capital 2.11 FDA 3.16(a) Financial Statements 3.6(a) Holdback Shares 2.1(b) Indemnified Party 8.2(e) Indemnifying Party 8.2(e) Independent Accounting Firm 2.12(c) Insiders 3.21 Item of Dispute 2.12(a) Key Company Employees 6.1(e) Latest Balance Sheet 3.6(a) Leased Properties 3.9(b)